| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +1.22M | 100% | $5.93 | +$7.21M |
| Sells | 0 | ||||
| Net | +4 | +1.22M | 100% | +$7.21M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Third Rock Ventures VI, L.P. | 10%+ Owner | $62.6M | +$6.28M | +11.2% | Feb 24, 2025 |
| Third Rock Ventures V, L.P. | 10%+ Owner | $54.8M | Oct 28, 2024 | ||
| Ra Capital Management, L.P. | Director, 10%+ Owner | $8.61M | Oct 28, 2024 | ||
| Jeffrey Finer | CEO and President, Director | $2.28M | +$97K | +4.44% | Apr 2, 2025 |
| Elizabeth Bhatt | Chief Operating Officer | $1.02M | Oct 24, 2024 | ||
| Alan Ezekowitz | Director | $813K | +$608K | +296% | Mar 7, 2025 |
| Uwe Klein | SVP, Biological Sciences | $611K | Oct 24, 2024 | ||
| Daniel D. Long | SVP, Drug Discovery | $544K | Oct 24, 2024 | ||
| Ran Xiao | Interim CFO | $340K | Oct 24, 2024 | ||
| Gil M. Labrucherie | Chief Financial Officer | $234K | +$229K | +4739% | Feb 25, 2025 |
| Jae B. Kim | Chief Medical Officer | Oct 24, 2024 | |||
| Shalini Sharp | Director | Oct 24, 2024 | |||
| Jake Simson | Director | Oct 24, 2024 | |||
| Bernard Coulie | Director | Oct 24, 2024 | |||
| Jeffrey K. Tong | Director | Oct 24, 2024 | |||
| Abraham Bassan | Director | Oct 24, 2024 | |||
| Samira Shaikhly | Chief People Officer | Oct 24, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|